Senores Pharmaceuticals Stock Forecast

Buy or Hold candidate since May 06, 2026 Gain 45.95%

The Senores Pharmaceuticals Ltd. stock price gained 1.77% on the last trading day (Thursday, 2nd Jul 2026), rising from ₹1,313.10 to ₹1,336.40. During the last trading day the stock fluctuated 2.82% from a day low at ₹1,303.00 to a day high of ₹1,339.80. The price has fallen in 6 of the last 10 days but is still up by 5.24% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 8 thousand more shares were traded than the day before. In total, 208 thousand shares were bought and sold for approximately ₹277.37 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 66.29% during the next 3 months and, with a 90% probability hold a price between ₹1,943.29 and ₹2,300.31 at the end of this 3-month period.

SENORES.NS Signals & Forecast

Mostly positive signals in the chart today. The Senores Pharmaceuticals Ltd. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at ₹1,304.29 and ₹1,159.57. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, June 08, 2026, and so far it has risen 32.71%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Senores Pharmaceuticals Ltd. stock

Senores Pharmaceuticals Ltd. finds support from accumulated volume at ₹1,290.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved ₹36.80 between high and low, or 2.82%. For the last week, the stock has had daily average volatility of 3.51%.

Our recommended stop-loss: ₹1,288.86 (-3.56%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 17 days ago.)

Trading Expectations (SENORES.NS) For The Upcoming Trading Day Of Friday 3rd

For the upcoming trading day on Friday, 3rd we expect Senores Pharmaceuticals Ltd. to open at ₹1,326.40, and during the day (based on 14 day Average True Range), to move between ₹1,309.14 and ₹1,363.66, which gives a possible trading interval of +/-₹54.53 (+/-4.17%) up or down from last closing price. If Senores Pharmaceuticals Ltd. takes out the full calculated possible swing range there will be an estimated 4.17% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ ₹1,290.00, some ₹46.40 (3.47%) from the current price of ₹1,336.40, our system finds the risk reward attractive.

Is Senores Pharmaceuticals Ltd. stock A Buy?

Senores Pharmaceuticals Ltd. holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

Current score: 5.266 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 3, 2026 - ₹1,326.40 ( 0.748%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk